Evidence map›Paper›PMID 22500026›Full record

ArticleThe Journal of biological chemistry2012

Low-density lipoprotein receptor deficiency causes impaired osteoclastogenesis and increased bone mass in mice because of defect in osteoclastic cell-cell fusion.

Mari Okayasu, Mai Nakayachi, Chiyomi Hayashida, Junta Ito, Toshio Kaneda, Masaaki Masuhara, Naoto Suda, Takuya Sato, Yoshiyuki Hakeda

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Bone metabolism - an underappreciated player.npj metabolic health and disease · 2024
    Review
  3. Obesity and lipid metabolism in the development of osteoporosis (Review).International journal of molecular medicine · 2024
    Review
  4. Review
  5. TRPV4-dependent CaBiophysical journal · 2024
    Article
  6. Review
  7. Article
  8. Novel Insights into Osteoclast Energy Metabolism.Current osteoporosis reports · 2023
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Frontiers in cellular and infection microbiology · 2022
    Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Metabolic reprogramming in osteoclasts.Seminars in immunopathology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Mari OkayasuDivision of Oral Anatomy, Department of Human Development and Fostering, Meikai University School of Dentistry, Sakado, Saitama 350-0283, Japan.
Mai Nakayachi
Chiyomi Hayashida
Junta Ito
Toshio Kaneda
Masaaki Masuhara
Naoto Suda
Takuya Sato
Yoshiyuki Hakeda
Meikai University · JPHoshi University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteoporosis is associated with both atherosclerosis and vascular calcification attributed to hyperlipidemia. However, the cellular and molecular mechanisms explaining the parallel progression of these diseases remain unclear. Here, we used low-density lipoprotein receptor knockout (LDLR(-/-)) mice to elucidate the role of LDLR in regulating the differentiation of osteoclasts, which are responsible for bone resorption. Culturing wild-type osteoclast precursors in medium containing LDL-depleted serum decreased receptor activator of NF-κB ligand (RANKL)-induced osteoclast formation, and this defect was additively rescued by simultaneous treatment with native and oxidized LDLs. Osteoclast precursors constitutively expressed LDLR in a RANKL-independent manner. Osteoclast formation from LDLR(-/-) osteoclast precursors was delayed, and the multinucleated cells formed in culture were smaller and contained fewer nuclei than wild-type cells, implying impaired cell-cell fusion. Despite these findings, RANK signaling, including the activation of Erk and Akt, was normal in LDLR(-/-) preosteoclasts, and RANKL-induced expression of NFATc1 (a master regulator of osteoclastogenesis), cathepsin K, and tartrate-resistant acid phosphatase was equivalent in LDLR-null and wild-type cells. In contrast, the amounts of the osteoclast fusion-related proteins v-ATPase V(0) subunit d2 and dendritic cell-specific transmembrane protein in LDLR(-/-) plasma membranes were reduced when compared with the wild type, suggesting a correlation with impaired cell-cell fusion, which occurs on the plasma membrane. LDLR(-/-) mice consistently exhibited increased bone mass in vivo. This change was accompanied by decreases in bone resorption parameters, with no changes in bone formation parameters. These findings provide a novel mechanism for osteoclast differentiation and improve the understanding of the correlation between osteoclast formation and lipids.

Indexed as

Cell DifferentiationMAP Kinase Signaling SystemAnimalsBone and BonesBone ResorptionCell FusionCell MembraneCells, CulturedExtracellular Signal-Regulated MAP KinasesGene Expression RegulationHumansMiceMice, KnockoutNFATC Transcription FactorsOrgan SizeOsteoclastsExtracellular Signal-Regulated MAP KinasesNfatc1 protein, mouseNFATC Transcription FactorsProto-Oncogene Proteins c-aktRANK LigandReceptors, LDLTnfsf11 protein, mouseVacuolar Proton-Translocating ATPases

Identifiers

PMID22500026
PMCPMC3365955
OpenAlexW2056184328

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.